SearchipHandbook Blog
Your source for expert commentary on IP management issues.
In ipHandbook Forums
|
Home > Author Index > KEILLER, Todd S KEILLER, Todd S
Contributions
|
|
About the ipHandbook | Policies and Disclaimers | Contact Us | Site Map
Developed with support from the Rockefeller Foundation. Distributed through Sponsorship.
©2007-2009. Concept Foundation, PIPRA, FIOCRUZ and bioDevelopments-Int.
Institute. Copyright and use. 
Printer Friendly
Todd S. Keiller has more than 30 years of licensing, business development, and marketing experience. He has worked for 16 years in the industrial sector in a variety of sales, marketing, and business development roles, ten of which were in the Science and Medical Products Divisions of Corning Glass Works. He has over 16 years of academic licensing experience and is the former Vice President, Ventures of the Brigham and Women’s Hospital in Boston. In 1998, Todd joined the University of Vermont and assisted the College of Medicine in technology affairs. In 1999, he was appointed Director of Technology Transfer for the entire University. He also handles technology transfer for Maine Medical Center, Caritas St. Elizabeth’s Medical Center of Boston, and Boston Biomedical Research Institute. Mr. Keiller has contributed to the foundation of seven companies, the most recent of which are Nephromics (a company focused on the diagnosis of preeclampsia), Vascular Genetics, Inc. (a gene therapy company, now traded publicly under the name of CorAutus), and Tolerance Pharmaceuticals (a diagnostic and therapeutic company devoted to transplantation, which was purchased by Roche). Mr. Keiller holds an A.B. from Dartmouth College and an M.B.A. from the Tuck School of Business Administration.
Show All Abstracts
Abstract